Press Releases about Celldex Therapeutics, Inc. - Common Stock

Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis
December 19, 2024
Via GlobeNewswire


Celldex Therapeutics to Present at Upcoming Investor Conferences
November 11, 2024
Via GlobeNewswire





Celldex Therapeutics to Present at Upcoming Investor Conferences
September 12, 2024
Via GlobeNewswire













Celldex Therapeutics Announces Proposed Public Offering of Common Stock
February 28, 2024
Via GlobeNewswire






Via GlobeNewswire

Celldex Therapeutics Announces Proposed Public Offering of Common Stock
November 07, 2023
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.